Deep brain stimulation (DBS) is a neurosurgical procedure involving the implantation of a medical device called a neurostimulator (sometimes referred to as a 'brain pacemaker'), which sends electrical impulses, through implanted electrodes, to specific targets in the brain (brain nuclei) for the treatment of movement and neuropsychiatric disorders. DBS in select brain regions has provided therapeutic benefits for otherwise-treatment-resistant disorders such as Parkinson's disease, essential tremor, dystonia, chronic pain, major depression and obsessive–compulsive disorder (OCD). Despite the long history of DBS, its underlying principles and mechanisms are still not clear. DBS directly changes brain activity in a controlled manner, its effects are reversible (unlike those of lesioning techniques), and it is one of only a few neurosurgical methods that allow blinded studies.
This report contains market size and forecasts of Deep Brain Stimulation (DBS) in global, including the following market information:
Global Deep Brain Stimulation (DBS) Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Deep Brain Stimulation (DBS) Market Sales, 2017-2022, 2023-2028, (Units)
Global top five Deep Brain Stimulation (DBS) companies in 2021 (%)
The global Deep Brain Stimulation (DBS) market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Single-channel DBS Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Deep Brain Stimulation (DBS) include Medtronic, Boston Scientific, Abbott, Beijing Pins and SceneRay, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Deep Brain Stimulation (DBS) manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Deep Brain Stimulation (DBS) Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Units)
Global Deep Brain Stimulation (DBS) Market Segment Percentages, by Type, 2021 (%)
Single-channel DBS
Dual-channel DBS
Global Deep Brain Stimulation (DBS) Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Units)
Global Deep Brain Stimulation (DBS) Market Segment Percentages, by Application, 2021 (%)
Parkinson's Disease
Essential Tremor
Dystonia
Others
Global Deep Brain Stimulation (DBS) Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Units)
Global Deep Brain Stimulation (DBS) Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Deep Brain Stimulation (DBS) revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Deep Brain Stimulation (DBS) revenues share in global market, 2021 (%)
Key companies Deep Brain Stimulation (DBS) sales in global market, 2017-2022 (Estimated), (Units)
Key companies Deep Brain Stimulation (DBS) sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Medtronic
Boston Scientific
Abbott
Beijing Pins
SceneRay